Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trilipix and statin therapy in mixed dyslipidemia (Year 2 Extension)
NCT00491530Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of fenofibric acid in mixed dyslipidemia, sponsored by Abbott Laboratories. Started Jun 2007; status: completed.
02
Drugs
fenofibric acid
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT00491530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00491530.